Lung India

CASE REPORT
Year
: 2021  |  Volume : 38  |  Issue : 7  |  Page : 69--71

Use of endobronchial valve to treat COVID-19 adult respiratory distress syndrome-related alveolopleural fistula


Vikas Pathak, John Waite, Som Nath Chalise 
 Department of Pulmonary and Critical Care, Riverside Health System, Newport News, VA, USA

Correspondence Address:
Dr. Vikas Pathak
500 J Clyde Morris Blvd, Newport News, VA
USA

Coronavirus disease-2019 (COVID-19) pneumonia is one of the severe and most dreaded forms of illness caused by severe acute respiratory syndrome coronavirus 2. It often progresses to respiratory failure and acute respiratory distress syndrome (ARDS) requiring mechanical ventilation. ARDS can lead to multiple complications while on mechanical ventilation due to positive airway pressures in a fibrotic lung, one such complication is the development of alveolopleural fistula. Alveolopleural fistula has high morbidity and mortality. We used endobronchial valve in a patient with COVID-19-related ARDS with persistent air leak (alveolopleural fistula), which allowed us to remove the chest tube and wean the patient successfully off mechanical ventilation.


How to cite this article:
Pathak V, Waite J, Chalise SN. Use of endobronchial valve to treat COVID-19 adult respiratory distress syndrome-related alveolopleural fistula.Lung India 2021;38:69-71


How to cite this URL:
Pathak V, Waite J, Chalise SN. Use of endobronchial valve to treat COVID-19 adult respiratory distress syndrome-related alveolopleural fistula. Lung India [serial online] 2021 [cited 2021 May 15 ];38:69-71
Available from: https://www.lungindia.com/article.asp?issn=0970-2113;year=2021;volume=38;issue=7;spage=69;epage=71;aulast=Pathak;type=0